Seaside Ventures

Seaside Ventures is a San Diego-based accelerator that has positioned itself at the intersection of digital health and AI, and the firm reflects a particular kind of West Coast healthcare investing that draws on the city’s deep biotech and medical device heritage without confining itself to those traditional categories. The program writes $50k-$500k checks at pre-seed and seed, runs accelerator-style cohorts, and tends to back founders who want structured programmatic support alongside capital.

The declared sub-verticals are digital health and AI/ML in healthcare. In practice that means interest in clinical software, care delivery technology, AI applications inside healthcare workflows, and tools that bridge the San Diego biotech ecosystem with broader digital health categories. The firm is less active in pure therapeutics, in hardware-only medical devices that fit traditional venture timelines, or in consumer wellness without clinical depth. The strongest fits are companies that benefit from cohort-based programming, structured mentorship, and access to the regional clinical and biotech network that San Diego concentrates.

Check sizes of $50k-$500k and the accelerator framing place Seaside firmly at the entry-point end of the cap table. The role is to help founders go from idea to funded seed round rather than to lead institutional rounds. Geographically the focus is San Diego and the broader US, with particular density in companies that can plug into the city’s clinical and life-sciences ecosystem. Founders should treat the accelerator format as a real commitment of time and engagement rather than a passive investment, and should evaluate the program structure against the stage they are at and the help they actually need.

The team and program are built around the structure that accelerators run on: cohort programming, mentor networks, structured curriculum, and demo-day-style fundraising support. Diligence at the pre-seed level tends to be more about the founder and the early thesis than about extensive technical or commercial validation, which fits the stage. Founders should expect engagement that is more programmatic and less individualized than a traditional seed fund, although the relationships built during the cohort can extend well past the program itself.

For founders, the practical read is that Seaside is a credible accelerator for early-stage healthcare AI and digital health companies, particularly those that want San Diego-anchored support and access to the regional clinical network. It is less useful for founders who already have institutional seed capital, who do not benefit from a programmatic structure, or who are building outside the digital health and AI scope. The engagement style is cohort-driven and supportive at the entry stage, and the most valuable graduates tend to be those who use the program to set up the seed round that follows. Founders fitting that profile and looking for a regionally anchored accelerator with a serious healthcare thesis should consider Seaside a reasonable early-stage option.